Advanced Excipient Technology from Vitaldose EVA Excipient @ CRS annual Meeting

30. June 2016

VITALDOSE® EVA—AN EFFECTIVE DRUG DELIVERY TECHNOLOGY

Our custom controlled release ethylene vinyl acetate, VitalDose® EVA, is improving pharmaceutical drug delivery applications around the world. VitalDose EVA is safe and dependable, and has performed effectively in controlled release applications for more than 20 years. Attend our technical presentation to see how our controlled release EVA is improving drug delivery technology.

 

Join us at the 2016 Controlled Release Society (CRS) Annual Meeting & Exposition July 17-20, 2016 in Seattle, Washington.

Booth #409

 

Celanese Poster Presentation:

Hot-melt Extrusion Processability: The low temperature hot-melt extrusion processability of ethylene vinyl acetate copolymers as pharmaceutical controlled release excipients.

 

Presenter:

Dirk Hair, T&I Manager – Product Development

 

Date/Time:

Sunday, July 17, 2016 – 4:30pm to 6:30pm

Monday, July 18, 2016 – 12:30pm to 1pm

Tuesday, July 19th – 8:00am to 9:30am

*See poster #213 for additional times

 

VitalDose EVA can be used in a wide array of applications, including:

– Intraoral

– Intravaginal

– Ocular

– Rectal

– Subcutaneous

– Transdermal

 

Additional VitalDose® EVA advantages:

– Optically transparent and breathable

– Flexible, customer solutions

– FDA and EU food contact compliant

– Comprehensive regulatory knowledge and support

– Clinically accepted worldwide

 

 

You might also like